These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149 [TBL] [Abstract][Full Text] [Related]
3. Insights into the variability of nasal potential difference, a biomarker of CFTR activity. Kyrilli S; Henry T; Wilschanski M; Fajac I; Davies JC; Jais JP; Sermet-Gaudelus I J Cyst Fibros; 2020 Jul; 19(4):620-626. PubMed ID: 31699569 [TBL] [Abstract][Full Text] [Related]
4. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis? Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796 [TBL] [Abstract][Full Text] [Related]
5. Nasal potential difference in congenital bilateral absence of the vas deferens. Pradal U; Castellani C; Delmarco A; Mastella G Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023 [TBL] [Abstract][Full Text] [Related]
6. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF). Sands D Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691 [TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A. Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M Respiration; 2006; 73(5):698-704. PubMed ID: 16763370 [TBL] [Abstract][Full Text] [Related]
9. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? Ooi CY; Dupuis A; Ellis L; Jarvi K; Martin S; Ray PN; Steele L; Kortan P; Gonska T; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P Thorax; 2014 Mar; 69(3):254-60. PubMed ID: 24149827 [TBL] [Abstract][Full Text] [Related]
10. Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey. Naehrlich L; Ballmann M; Davies J; Derichs N; Gonska T; Hjelte L; van Konigsbruggen-Rietschel S; Leal T; Melotti P; Middleton P; Tümmler B; Vermeulen F; Wilschanski M; J Cyst Fibros; 2014 Jan; 13(1):24-8. PubMed ID: 24022019 [TBL] [Abstract][Full Text] [Related]
11. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854 [TBL] [Abstract][Full Text] [Related]
12. Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis? Keenan K; Avolio J; Rueckes-Nilges C; Tullis E; Gonska T; Naehrlich L J Cyst Fibros; 2015 May; 14(3):310-6. PubMed ID: 25300456 [TBL] [Abstract][Full Text] [Related]
13. Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism. Aalbers BL; Yaakov Y; Derichs N; Simmonds NJ; De Wachter E; Melotti P; De Boeck K; Leal T; Tümmler B; Wilschanski M; Bronsveld I J Cyst Fibros; 2020 Jul; 19(4):627-631. PubMed ID: 31331863 [TBL] [Abstract][Full Text] [Related]
14. Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Gonska T; Ip W; Turner D; Han WS; Rose J; Durie P; Quinton P Thorax; 2009 Nov; 64(11):932-8. PubMed ID: 19734129 [TBL] [Abstract][Full Text] [Related]
15. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis. Ho LP; Samways JM; Porteous DJ; Dorin JR; Carothers A; Greening AP; Innes JA Eur Respir J; 1997 Sep; 10(9):2018-22. PubMed ID: 9311495 [TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955 [TBL] [Abstract][Full Text] [Related]
17. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis. Davies MG; Geddes DM; Alton EW Am J Respir Crit Care Med; 2005 Apr; 171(7):760-3. PubMed ID: 15618459 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis. Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'ava-Santucci J; Dusser D J Cyst Fibros; 2004 Mar; 3(1):15-22. PubMed ID: 15463882 [TBL] [Abstract][Full Text] [Related]
19. Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study. Bagheri-Hanson A; Nedwed S; Rueckes-Nilges C; Naehrlich L BMC Pulm Med; 2014 Oct; 14():156. PubMed ID: 25280757 [TBL] [Abstract][Full Text] [Related]
20. Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population. Sad IR; Higa LY; Leal T; Martins Rda S; de Almeida AC; Ramos EG; de Cabello GM; Peixoto MV J Clin Med Res; 2016 Jan; 8(1):15-24. PubMed ID: 26668678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]